Instem
Instem provides software solutions and services for life sciences, specializing in areas like genetic toxicology, preclinical studies, and clinical trial analytics, with a global presence and a focus on regulatory compliance.
Services
Instem offers a variety of software solutions and services tailored for the life sciences sector. These include genetic toxicology, preclinical studies, and clinical trial analytics. The company also provides cloud-based solutions like Accel for statistical computing and Aspire for clinical analytics. Additionally, Instem supports regulatory compliance by offering tools and services designed to meet FDA and other standards, including SEND solutions for electronic data submission. A key service is the technology-enabled Predict™ for in silico toxicology predictions.
Software Solutions
Instem provides several specialized software solutions. Provantis is designed for preclinical study management, Comet Assay IV is used for DNA damage assessment, and NOTOCORD-hem facilitates physiological signal analysis. These software solutions help streamline operations and improve data accuracy in respective fields.
Regulatory Compliance Support
Instem offers comprehensive support for regulatory compliance, specifically tailored to meet FDA and other global standards. Services include data conversion, validation, and consultancy, particularly focusing on SEND compliance. These tools and services ensure that electronic data submissions adhere to regulatory requirements.
Global Operations
Instem operates on a global scale, with offices located in the United States, United Kingdom, France, China, and Japan. This global presence enables the company to serve a diverse range of clients across various regions, ensuring accessibility and local support.
Strategic Partnerships
Instem engages in strategic partnerships to broaden its product reach and enhance capabilities. These partnerships include distribution agreements, consultancy arrangements, and co-development projects. Such collaborations help the company to innovate and expand its offerings in the life sciences sector.